Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Doc Bones who wrote (10473)	2/18/2004 11:43:09 AM
From: Biomaven	Read Replies (2) \| Respond to of 52153

Welcome news today on Antegren. But the relative price performance of the two companies involved is interesting. Coincidentally, ELN and BIIB have about the same number of shares outstanding. But BIIB went up $9 and ELN went up $2.25. In fact, in my view ELN should by rights go up a little more in total dollar terms than BIIB simply because ELN's finances are still a little cloudy and this removes some risk from the stock. Wonder if BIIB is thinking about munching ELN? (I own ELN but not BIIB). Peter